The challenge of cost-effectiveness research on first-episode psychosis

Br J Psychiatry. 2019 Jul;215(1):386-387. doi: 10.1192/bjp.2019.78.

Abstract

Early intervention in psychosis has generated hope. Cost-effectiveness studies, to determine whether benefits exceed costs, thus far conclude only that early intervention 'might be' worth its costs. It is a testament to the importance of the question: even in the absence of conclusive data, a synthesis should be attempted.Declaration of interestNone.

Keywords: Early intervention; cost-effectiveness; schizophrenia.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Cost-Benefit Analysis
  • Humans
  • Psychotic Disorders*
  • Schizophrenia*